AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin

#biotechnology

Related Stories (20)

Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion - Reuters

Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion Reuters

October 5, 2026

CSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis - Reuters

CSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis Reuters

October 4, 2026

Novartis strikes up to $7.8 billion mRNA deal with China's Abogen - Reuters

Novartis strikes up to $7.8 billion mRNA deal with China's Abogen Reuters

October 2, 2026

China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion - Reuters

China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion Reuters

September 24, 2026

Anthropic says Claude AI helped discover novel enzyme system - Reuters

Anthropic says Claude AI helped discover novel enzyme system Reuters

September 23, 2026

Use of untested 'Wolverine' peptide backed by US Health Secretary Kennedy on the rise, study finds - Reuters

Use of untested 'Wolverine' peptide backed by US Health Secretary Kennedy on the rise, study finds Reuters

September 15, 2026

Scholar Rock gets first FDA nod for rare muscle-wasting disease - Reuters

Scholar Rock gets first FDA nod for rare muscle-wasting disease Reuters

September 11, 2026

Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology - Reuters

Novartis signs deal worth up to $3.2 billion for Alteogen's drug delivery technology Reuters

September 2, 2026

Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push - Reuters

Lilly to buy Merida Biosciences for up to $2.88 billion in autoimmune drug push Reuters

August 31, 2026

Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters

Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough Reuters

August 28, 2026

Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters

Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters

August 26, 2026

The Merck/Moderna cancer vaccine: How does it work and what are potential barriers to wide use? - Reuters

The Merck/Moderna cancer vaccine: How does it work and what are potential barriers to wide use? Reuters

August 25, 2026

Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder - Reuters

Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder Reuters

August 19, 2026

Moderna, Merck breakthrough could usher in wave of cancer vaccines - Reuters

Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters

August 19, 2026

Capricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters

Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters

August 14, 2026

Lawsuit against Bristol Myers over delayed cancer drug is revived - Reuters

Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters

August 13, 2026

US FDA approves Replimune's skin cancer drug after prior rejections - Reuters

US FDA approves Replimune's skin cancer drug after prior rejections Reuters

August 6, 2026

Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition - Reuters

Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition Reuters

August 6, 2026

US FDA approves first mRNA flu shot from Moderna - Reuters

US FDA approves first mRNA flu shot from Moderna Reuters

August 6, 2026

Tempus to buy cancer test maker Personalis for $1.5 billion - Reuters

Tempus to buy cancer test maker Personalis for $1.5 billion Reuters

July 20, 2026

Related Pages (20)

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•October 5, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•October 5, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•October 2, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•September 24, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•September 16, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•September 12, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•August 31, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•August 28, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•August 26, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•August 20, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•August 14, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•August 7, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•August 6, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•August 6, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•July 16, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•July 7, 2026

Amgen owes $20.2 million in antibody patent lawsuit, US jury says

(()=>{"use strict";window.initData=window.initData||{},window.initData.block_widgetbar=function(i,t,a,n,e){function w(a){const w={resizerBridge:t.allocate({areaName:"right"}),affectsLayout:()=>!0,adap

tradingview.com•June 17, 2026

China’s WuXi sues US over allegations it supports Beijing’s military

By Nikita Maria Jino, Kumar Tanishk and Jonathan Stempel June 11 (Reuters) – A Chinese biotechnology company sued the U.S. government on Thursday over being placed on a list of businesses from China

wkzo.com•June 14, 2026

China’s WuXi sues US over allegations it supports Beijing’s military

By Nikita Maria Jino, Kumar Tanishk and Jonathan Stempel June 11 (Reuters) – A Chinese biotechnology company sued the U.S. government on Thursday over being placed on a list of businesses from China

947thebeast.com•June 14, 2026

Untitled

window.wiz_progress&&window.wiz_progress();window.wiz_tick&&window.wiz_tick('lW1Lhc');(function(){'use strict';var c=window,d=[];c.aft_counter=d;var e=[],f=0;function _recordIsAboveFold(a){if(!c._isLa

news.google.com•June 12, 2026